STLNWNasdaq United StatesHealth CareMedical/Nursing Services
Market cap
$5.911 M
$0.06 +0.00%
Close of 21 Aug 2026
Revenue
$502.7M
#1906 by revenue
Earnings
$60.6B
#8 by earnings
Shares outstanding
101,916,115
Latest filing cover page
P/E ratio
0.0
Cap ÷ net income
Other share classes
Starling Oncology lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for Starling Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 21 Aug 2026. Read the methodology.
Insiders buying
All insider buying →One open-market purchase by officers and directors of Starling Oncology, worth $78.5K. Grants and option exercises are excluded.
12,000 shares at $6.54 on 14 Aug 2026 · filed 17 Aug 2026